CHANGZHOU, China, October 27, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced its participation in the following investor events:
- Bank of America Merrill Lynch New China Conference to be held on October 31 - November 4, 2011 at the JW Marriot Hotel in Beijing, China. Management is scheduled to meet with institutional investors on November 2, 2011.
- CLSA AsiaUSA Forum to be held on November 7 - 9, 2011 at the Palace Hotel in San Francisco. Management is scheduled to present on November 7, 2011 at 11.30 a.m. and meet with institutional investors throughout the day.
- Cowen China Opportunity Inaugural Conference to be held on November 15 - 16, 2011 at the St. Regis Hotel in Beijing, China. Management is scheduled to present on November 15, 2011 at 9 a.m. and meet with institutional investors throughout the day.
- Lazard Capital Markets 8th Annual Healthcare Conference to be held on November 15 - 16, 2011 at the Pierre Hotel in New York City. Management is scheduled to present on November 15, 2011 at 8.30 a.m. and meet with institutional investors throughout the day.
- Morgan Stanley Asia Pacific Summit to be held on November 16 - 17, 2011 at Mandarin Oriental Hotel in Singapore. Management is scheduled to meet with institutional investors throughout the 2 days.
- Piper Jaffray 23rd Annual Healthcare Conference to be held on November 29 - 30, 2011 at the New York Palace Hotel in New York City. Management is scheduled to present on November 30, 2011 at 3 p.m. and meet with institutional investors throughout the day.
- Oppenheimer & Co. 22nd Annual Healthcare Conference to be held on December 13 - 14, 2011 at the Waldorf Astoria Hotel in New York City. Management is scheduled to present on December 13, 2011 at 8.50 a.m. and meet with institutional investors throughout the day.
About China Kanghui Holdings
Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghui's products are distributed in 28 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit www.kanghui.com.
Contact:
China Kanghui Holdings Investor Relations Department
+1-888-321-2558
Asia Bridge Capital Limited
Carene Toh
+86-186 1835 6339
carene.toh@asiabridgegroup.com
